Toggle Main Menu Toggle Search

Open Access padlockePrints

Nuclear Alpha-Synuclein: Mechanisms and Implications for Synucleinopathies

Lookup NU author(s): Professor Tiago OuteiroORCiD, Dr David KossORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 International Parkinson and Movement Disorder Society.Alpha-synuclein (aSyn), historically studied for its synaptic functions and central role in Lewy body pathology, is emerging as a protein with significant nuclear activities relevant to Parkinson's disease (PD) and related synucleinopathies. Recent advances reveal that aSyn dynamically localizes to neuronal nuclei in both health and disease, where its interactions with chromatin and DNA may contribute to the regulation of genomic stability, DNA damage responses, and cellular aging. Studies using experimental models demonstrate that nuclear aSyn promotes neurodegeneration through transcriptional dysregulation, DNA repair deficits, and cellular senescence, especially when present in phosphorylated or oligomeric forms. The detection of nuclear aSyn in human tissues has proven challenging, but improvements in immunohistochemical and molecular techniques now allow deeper exploration of its physiological and pathological states. Mechanistic studies indicate that aSyn can modulate nuclear import pathways and directly interact with genomic repair machinery, suggesting new avenues for disease modification. As such, nuclear aSyn represents both a promising biomarker for disease stratification and a potential therapeutic target. Integrating mechanistic, biomarker, and translational research on nuclear aSyn may transform our understanding of PD progression and enable precision medicine approaches for early diagnosis and intervention in synucleinopathies. © 2025 International Parkinson and Movement Disorder Society.


Publication metadata

Author(s): Outeiro TF, Koss DJ

Publication type: Article

Publication status: Published

Journal: Movement Disorders

Year: 2025

Pages: epub ahead of print

Online publication date: 14/11/2037

Acceptance date: 26/11/2025

Date deposited: 27/01/2026

ISSN (print): 0885-3185

ISSN (electronic): 1531-8257

Publisher: John Wiley and Sons Inc

URL: https://doi.org/10.1002/mds.70138

DOI: 10.1002/mds.70138

Data Access Statement: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

PubMed id: 41293789


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy, EXC 2067/1-390729940 SFB1286 (B6 and B8)
The Lewy Body Society (LBS2022-007 and LBS2024-005)

Share